Search

Fred H. Reynolds

Examiner (ID: 8556, Phone: (571)270-7214 , Office: P/1675 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1658, 1675
Total Applications
1158
Issued Applications
386
Pending Applications
177
Abandoned Applications
614

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18970433 [patent_doc_number] => 20240050525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS [patent_app_type] => utility [patent_app_number] => 18/259092 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259092 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/259092
METHODS OF TREATING, DIAGNOSING AND PREDICTING PROGNOSIS OF SEPSIS Jan 30, 2022 Pending
Array ( [id] => 19121046 [patent_doc_number] => 11965016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Crystal structures comprising elastin-like peptides [patent_app_type] => utility [patent_app_number] => 17/588579 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 39 [patent_no_of_words] => 26751 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588579 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588579
Crystal structures comprising elastin-like peptides Jan 30, 2022 Issued
Array ( [id] => 17760092 [patent_doc_number] => 20220233704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/586258 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11584 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586258 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/586258
MUTANTS AND DRUG CONJUGATES OF R-SPONDINS AND USE THEREOF Jan 26, 2022 Pending
Array ( [id] => 17595331 [patent_doc_number] => 20220144904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => Composition for and Method of Improving Tissue Performance [patent_app_type] => utility [patent_app_number] => 17/583549 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583549 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/583549
Composition for and Method of Improving Tissue Performance Jan 24, 2022 Pending
Array ( [id] => 18075118 [patent_doc_number] => 20220400730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY AND OTHER USES [patent_app_type] => utility [patent_app_number] => 17/579408 [patent_app_country] => US [patent_app_date] => 2022-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579408 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/579408
COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY AND OTHER USES Jan 18, 2022 Abandoned
Array ( [id] => 19172469 [patent_doc_number] => 20240158443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => Compositions And Methods of Synthesizing Shape Shifting Cyclic Peptides (Sscp) And Their Use in The Identification of Novel Therapeutic Compounds [patent_app_type] => utility [patent_app_number] => 18/272674 [patent_app_country] => US [patent_app_date] => 2022-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272674 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/272674
Compositions and methods of synthesizing shape shifting cyclic peptides (Sscp) and their use in the identification of novel therapeutic compounds Jan 18, 2022 Issued
Array ( [id] => 19049350 [patent_doc_number] => 20240091319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS [patent_app_type] => utility [patent_app_number] => 18/272549 [patent_app_country] => US [patent_app_date] => 2022-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272549 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/272549
DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS Jan 17, 2022 Pending
Array ( [id] => 18107956 [patent_doc_number] => 20230000836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING [patent_app_type] => utility [patent_app_number] => 17/573304 [patent_app_country] => US [patent_app_date] => 2022-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573304 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/573304
PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING Jan 10, 2022 Abandoned
Array ( [id] => 17735005 [patent_doc_number] => 20220220464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => CHIMERIC LYSM POYLPEPTIDES [patent_app_type] => utility [patent_app_number] => 17/572524 [patent_app_country] => US [patent_app_date] => 2022-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572524 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/572524
CHIMERIC LYSM POYLPEPTIDES Jan 9, 2022 Abandoned
Array ( [id] => 17836454 [patent_doc_number] => 20220273759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/571283 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 168500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571283 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/571283
PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF Jan 6, 2022 Abandoned
Array ( [id] => 18108077 [patent_doc_number] => 20230000957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/569402 [patent_app_country] => US [patent_app_date] => 2022-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569402 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/569402
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME Jan 4, 2022 Abandoned
Array ( [id] => 17561789 [patent_doc_number] => 20220125938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => COMPOSITIONS AND METHODS FOR DISASSEMBLING AMYLOID FIBRILS [patent_app_type] => utility [patent_app_number] => 17/567667 [patent_app_country] => US [patent_app_date] => 2022-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567667 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/567667
COMPOSITIONS AND METHODS FOR DISASSEMBLING AMYLOID FIBRILS Jan 2, 2022 Abandoned
Array ( [id] => 19097751 [patent_doc_number] => 20240116979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHOD FOR PRODUCING LIPIDIC PEPTIDE [patent_app_type] => utility [patent_app_number] => 18/269716 [patent_app_country] => US [patent_app_date] => 2021-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269716 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/269716
METHOD FOR PRODUCING LIPIDIC PEPTIDE Dec 23, 2021 Pending
Array ( [id] => 17546759 [patent_doc_number] => 20220118100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => MONOFUNCTIONAL BRANCHED POLYETHYLENE GLYCOL AND MODIFIED BIO-RELATED SUBSTANCE THEREOF [patent_app_type] => utility [patent_app_number] => 17/561342 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561342 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/561342
MONOFUNCTIONAL BRANCHED POLYETHYLENE GLYCOL AND MODIFIED BIO-RELATED SUBSTANCE THEREOF Dec 22, 2021 Pending
Array ( [id] => 18986533 [patent_doc_number] => 20240058502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => MEDICAL DEVICE, AND HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/270396 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6697 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270396 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270396
MEDICAL DEVICE, AND HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Dec 16, 2021 Pending
Array ( [id] => 17609881 [patent_doc_number] => 20220152160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => DOSING REGIMEN [patent_app_type] => utility [patent_app_number] => 17/553008 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 565 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553008 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/553008
DOSING REGIMEN Dec 15, 2021 Abandoned
Array ( [id] => 17704559 [patent_doc_number] => 20220204565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => Cyclic Peptide Antiviral Agents and Methods Using Same [patent_app_type] => utility [patent_app_number] => 17/552087 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 405 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552087 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552087
Cyclic Peptide Antiviral Agents and Methods Using Same Dec 14, 2021 Abandoned
Array ( [id] => 19519926 [patent_doc_number] => 12121626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-22 [patent_title] => Blood coagulation-promoting silk fibroin-polypeptide electrospun membrane and preparation method thereof [patent_app_type] => utility [patent_app_number] => 17/542473 [patent_app_country] => US [patent_app_date] => 2021-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2255 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542473 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/542473
Blood coagulation-promoting silk fibroin-polypeptide electrospun membrane and preparation method thereof Dec 4, 2021 Issued
Array ( [id] => 17625868 [patent_doc_number] => 20220160883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION [patent_app_type] => utility [patent_app_number] => 17/541636 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8345 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541636 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/541636
ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION Dec 2, 2021 Abandoned
Array ( [id] => 18861894 [patent_doc_number] => 20230416329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/039218 [patent_app_country] => US [patent_app_date] => 2021-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47000 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 336 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039218 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039218
A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF Nov 28, 2021 Pending
Menu